Sanofi has stopped further work on amcenestrant, a treatment once seen to have strong commercial potential in breast cancer after a second trial failure dealt a major blow to the French healthcare company’s development prospects. The move weighed on shares and mounted pressure on Sanofi to bolster its pipeline of …
Read More »EU starts real-time review of Sanofi-GSK coronavirus jab
Sanofi-GSK hopes to get approvals by the end of this year after early-stage results showed the vaccine produces a robust immune response. Europe’s drug regulator said on Tuesday it had started a real-time review of the COVID-19 vaccine developed by French drugmaker Sanofi and the UK’s GlaxoSmithKline, the fifth shot …
Read More »EU in talks with Moderna, BioNtech, CureVac to secure possible COVID vaccines, sources say
The European Union is negotiating advance purchase deals of potential COVID-19 vaccines with drugmakers Moderna, Sanofi, and Johnson & Johnson and biotech firms BioNtech and CureVac, two EU sources told Reuters. The talks follow a deal reached in June by four EU states with AstraZeneca for the upfront purchase of …
Read More »Moderna and Catalent Announce Collaboration for Fill-Finish Manufacturing of COVID-19 Vaccine
Moderna Inc said on Thursday it was partnering with contract drugmaker Catalent Inc to prepare an initial 100 million doses of its coronavirus vaccine for the United States, starting in the third quarter of this year. Catalent will fill and package doses, support production, and provide additional staffing for around-the-clock …
Read More »EU Insists Coronavirus Vaccine Be Available To All
The EU insisted Thursday that any vaccine against coronavirus must be available fairly to all countries after French drug giant Sanofi said it was reserving first shipments for the US. “The vaccine against COVID-19 should be a global public good and its access needs to be equitable and universal,” European …
Read More »